HIPK2 neutralizes MDM2 inhibition rescuing p53 transcriptional activity and apoptotic function

被引:58
作者
Di Stefano, V
Blandino, G
Sacchi, A
Soddu, S
D'Orazi, G
机构
[1] Regina Elena Inst Canc Res, Mol Oncogenesis Lab, Dept Expt Oncol, I-00158 Rome, Italy
[2] Univ G DAnnunzio, Dept Oncol & Neurosci, I-66013 Chieti, Italy
关键词
HIPK2; p53; ubiquitination; MDM2; nuclear export; apoptosis;
D O I
10.1038/sj.onc.1207656
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The p53 oncosuppressor protein is subject to negative regulation by MDM2, which efficiently inhibits its activity through an autoregulatory loop. In response to stress, however, p53 undergoes post-translational modi. cations that allow the protein to escape MDM2 control, accumulate, and become active. Recent studies have shown that, following DNA damage, the HIPK2 serine/ threonine kinase binds and phosphorylates p53, inducing p53 transcriptional activity and apoptotic function. Here, we investigated the role of HIPK2 in the activation of p53 in the presence of MDM2. We found that HIPK2 rescues p53 transcriptional activity overcoming MDM2 inhibition, and that restoration of this p53 function induces apoptosis. Recovery of p53-dependent apoptosis is achieved by preventing p53 nuclear export and ubiquitination mediated by MDM2 in vitro and in vivo following genotoxic stress. These results shed new light on the mechanisms by which the HIPK2/p53 pathway promotes apoptosis and suppression of tumorigenesis.
引用
收藏
页码:5185 / 5192
页数:8
相关论文
共 47 条
[1]   Post-translational modifications and activation of p53 by genotoxic stresses [J].
Appella, E ;
Anderson, CW .
EUROPEAN JOURNAL OF BIOCHEMISTRY, 2001, 268 (10) :2764-2772
[2]   MDM2 EXPRESSION IS INDUCED BY WILD TYPE-P53 ACTIVITY [J].
BARAK, Y ;
JUVEN, T ;
HAFFNER, R ;
OREN, M .
EMBO JOURNAL, 1993, 12 (02) :461-468
[3]   Phosphorylation of human p53 by p38 kinase coordinates N-terminal phosphorylation and apoptosis in response to UV radiation [J].
Bulavin, DV ;
Saito, S ;
Hollander, MC ;
Sakaguchi, K ;
Anderson, CW ;
Appella, E ;
Fornace, AJ .
EMBO JOURNAL, 1999, 18 (23) :6845-6854
[4]  
Chen JD, 1996, MOL CELL BIOL, V16, P2445
[5]   Inhibiting the p53-MDM2 interaction:: An important target for cancer therapy [J].
Chène, P .
NATURE REVIEWS CANCER, 2003, 3 (02) :102-109
[6]   Novel phosphorylation sites of human tumour suppressor protein p53 at Ser20 and Thr18 that disrupt the binding of mdm2 (mouse double minute 2) protein are modified in human cancers [J].
Craig, AL ;
Burch, L ;
Vojtesek, B ;
Mikutowska, J ;
Thompson, A ;
Hupp, TR .
BIOCHEMICAL JOURNAL, 1999, 342 :133-141
[7]   Homeodomain-interacting protein kinase-2 phosphorylates p53 at Ser 46 and mediates apoptosis [J].
D'Orazi, G ;
Cecchinelli, B ;
Bruno, T ;
Manni, I ;
Higashimoto, Y ;
Saito, S ;
Gostissa, M ;
Coen, S ;
Marchetti, A ;
Del Sal, G ;
Piaggio, G ;
Fanciulli, M ;
Appella, E ;
Soddu, S .
NATURE CELL BIOLOGY, 2002, 4 (01) :11-19
[8]   Homeodomain-interacting protein kinase-2 activity and p53 phosphorylation are critical events for cisplatin-mediated apoptosis [J].
Di Stefano, V ;
Rinaldo, C ;
Sacchi, A ;
Soddu, S ;
D'Orazi, G .
EXPERIMENTAL CELL RESEARCH, 2004, 293 (02) :311-320
[9]   Mdm2 overexpression and p14ARF inactivation are two mutually exclusive events in primary human lung tumors [J].
Eymin, B ;
Gazzeri, S ;
Brambilla, C ;
Brambilla, E .
ONCOGENE, 2002, 21 (17) :2750-2761
[10]   Nuclear export is required for degradation of endogenous p53 by MDM2 and human papillomavirus E6 [J].
Freedman, DA ;
Levine, AJ .
MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (12) :7288-7293